European Pharmaceutical Review
SEPTEMBER 22, 2023
Prior to joining Novimmune in 2002, she was Head of Immunology and Preclinical Pharmacology at the Serono Pharmaceutical Research Institute, a Senior Scientist and then Head of Immunology at the Glaxo Wellcome Research Institute in Geneva, and a Scientific Member of the Basel Institute for Immunology.
Pharmaceutical Technology
JULY 23, 2008
” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” . “And there’s a tremendous opportunity to meet their needs.”
World of DTC Marketing
JANUARY 27, 2022
In 2003 President George W. March-in rights under Bayh-Dole have never been invoked, no doubt because the Pharmaceutical Research and Manufacturers of America, or PhRMA, has made clear that it would litigate. That made them liable to the Bayh-Dole march-in rights over high prices or inadequate supply.
Expert insights. Personalized for you.
79 
Let's personalize your content